Other News To Note
• NeurOp Inc., of Atlanta, said New York-based Bristol-Myers Squibb Co. agreed to fund an additional year of research for NeurOp's small molecules in major depression and neuropathic pain. The funding extension continues the firms' 2009 agreement, under which BMS paid a $1.5 million licensing fee and NeurOp could receive up to $74 million in milestone payments and royalties.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter